Implications of LDL subclass B in patients at cardiovascular risk.
Moredich
Cheryl
C
School of Nursing, Purdue University Calumet, Hammond, Ind., USA.
Kark
Deborah
D
Keresztes
Patricia
P
D002318:Cardiovascular Diseases / Q000453:epidemiology / Q000209:etiology* / Q000517:prevention & control*; D008078:Cholesterol, LDL / Q000097:blood* / Q000145:classification / Q000187:drug effects; D018752:Diet, Fat-Restricted; D015444:Exercise; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D000960:Hypolipidemic Agents / Q000494:pharmacology / Q000627:therapeutic use; D008019:Life Style; D008403:Mass Screening; D009525:Niacin / Q000494:pharmacology / Q000627:therapeutic use; D009722:Nurse Practitioners / Q000458:organization & administration; D024802:Nurse's Role; D010353:Patient Education as Topic; D011320:Primary Health Care; D011322:Primary Prevention; D018570:Risk Assessment; D012307:Risk Factors; D040242:Risk Reduction Behavior; D012720:Severity of Illness Index; D014481:United States / Q000453:epidemiology
D008078:Cholesterol, LDL; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents; D009525:Niacin